Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |